Yesterday, CDC’s independent Advisory Committee on Immunization Practices (ACIP) recommended certain populations receive a booster shot of Pfizer-BioNTech’s COVID-19 Vaccine at least six months after the completion of their Pfizer vaccine primary series. In addition, the CDC Director recommended a booster dose for those in high risk occupational and institutional settings.
CDC recommends:
People 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series;
People aged 50 to 64 with certain underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series;
People 18 to 49 who are at high risk for severe COVID-19 due to certain underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks; and
People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.
The FDA’s and ACIP’s recommendations apply only to the Pfizer-BioNTech COVID-19 Vaccine with Moderna and Johnson & Johnson’s booster recommendations under review in the upcoming weeks.